Advancing age and insulin resistance : role of plasma tumor necrosis factor-a

In 70 healthy subjects with a large age range, the relationships between plasma tumor necrosis factor-α (TNF-α) and body composition, insulin action, and substrate oxidation were investigated. In the cross-sectional study ( n = 70), advancing age correlated with plasma TNF-α concentration ( r = 0.64, P < 0.001) and whole body glucose disposal (WBGD; r= -0.38, P < 0.01). The correlation between plasma TNF-α and age was independent of sex and body fat (BF; r = 0.31, P < 0.01). Independent of age and sex, a significant relationship between plasma TNF-α and leptin concentration ( r = 0.29, P < 0.02) was also found. After control for age, sex, BF, and waist-to-hip ratio (WHR), plasma TNF-α was still correlated with WBGD ( r = -0.33, P < 0.007). Further correction for plasma free fatty acid (FFA) concentration made the latter correlation no more significant. In a multivariate analysis, a model made by age, sex, BF, fat- free mass, WHR, and plasma TNF-α concentrations explained 69% of WBGD variability with age ( P < 0.009), BF ( P < 0.006), fat-free mass ( P < 0.005), and plasma TNF-α ( P < 0.05) significantly and independently associated with WBGD. In the longitudinal study, made with subjects at the highest tertiles of plasma TNF-α concentration ( n = 50), plasma TNF-α concentration predicted a decline in WBGD independent of age, sex, BF, WHR [relative risk (RR) = 2.0; 95% confidence intervals (CI) = 1.2-2.4]. After further adjustment for plasma fasting FFA concentration, the predictive role of fasting plasma TNF-α concentration on WBGD (RR = 1.2; CI = 0.8-1.5) was no more significant. In conclusion, our study demonstrates that plasma TNF-α concentration is significantly associated with advancing age and that it predicts the impairment in insulin action with advancing age.

[1]  M. Hickey,et al.  GENDER DIFFERENCES IN PLASMA LEPTIN CONCENTRATION ARE NOT INFLUENCED BY MENOPAUSE OR HORMONE REPLACEMENT THERAPY , 1998 .

[2]  J. Olefsky,et al.  TNF-α-Induced Insulin Resistance In Vivo and Its Prevention by Troglitazone , 1997, Diabetes.

[3]  W. Ricart,et al.  The TNF-α Gene Neo I Polymorphism Influences the Relationship Among Insulin Resistance, Percent Body Fat, and Increased Serum Leptin Levels , 1997, Diabetes.

[4]  W. Garvey,et al.  The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. , 1997, The Journal of clinical endocrinology and metabolism.

[5]  R. Vigneri,et al.  Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-a gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity , 1997, Diabetologia.

[6]  R. Eckel,et al.  Adipose tissue-derived tumor necrosis factor-alpha activity is elevated in older rats. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  C. Mantzoros,et al.  Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans. , 1997, The Journal of clinical endocrinology and metabolism.

[8]  L. Groop,et al.  Circulating TNF-alpha and Leptin Levels in Offspring of NIDDM Patients Do Not Correlate to Individual Insulin Sensitivity , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[9]  J. Friedman,et al.  Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. , 1996, The Journal of clinical investigation.

[10]  R. Henry,et al.  The expression of TNF alpha by human muscle. Relationship to insulin resistance. , 1996, The Journal of clinical investigation.

[11]  L. Mao,et al.  Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice. , 1996, Journal of immunology.

[12]  T. Hosokawa,et al.  Age-related enhancement of tumor necrosis factor (TNF) production in mice , 1995, Mechanisms of Ageing and Development.

[13]  E. Ravussin,et al.  Linkage between obesity and a marker near the tumor necrosis factor-alpha locus in Pima Indians. , 1995, The Journal of clinical investigation.

[14]  G. Paolisso,et al.  Glucose handling, diabetes and ageing. , 1995, Hormone research.

[15]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[16]  F. López‐Soriano,et al.  Cytokines and diabetes: the final step? Involvement of TNF-alpha in both type I and II diabetes mellitus. , 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[17]  B. Spiegelman,et al.  Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. , 1994, Endocrinology.

[18]  B. Spiegelman,et al.  Through thick and thin: Wasting, obesity, and TNFα , 1993, Cell.

[19]  K. Feingold,et al.  Role of Cytokines in Inducing Hyperlipidemia , 1992, Diabetes.

[20]  C H Lang,et al.  Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. , 1992, Endocrinology.

[21]  D. Goeddel,et al.  Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Deurenberg,et al.  Assessment of body composition by bioelectrical impedance in a population aged greater than 60 y. , 1990, The American journal of clinical nutrition.

[23]  P. Pekala,et al.  Monokine regulation of glucose transporter mRNA in L6 myotubes. , 1989, Biochemical and biophysical research communications.

[24]  E. Ferrannini The theoretical bases of indirect calorimetry: a review. , 1988, Metabolism: clinical and experimental.

[25]  A. Cerami,et al.  Lipoprotein Lipase Suppression in 3T3-L1 Cells by an Endotoxin-induced Mediator from Exudate Cells , 1984 .

[26]  V. Dole,et al.  Microdetermination of long-chain fatty acids in plasma and tissues. , 1960, The Journal of biological chemistry.